Safety and feasibility of fasting in combination with platinum-based chemotherapy

BMC Cancer

Volumn 16, Issue 1, 2016, Pages

  Dorff, Tanya B ^a   Groshen, Susan ^a   Garcia, Agustin ^a   Shah, Manali ^a   Tsao Wei, Denice ^a   Pham, Huyen ^a   Cheng, Chia Wei ^b   Brandhorst, Sebastian ^b   Cohen, Pinchas ^b   Wei, Min ^b   Longo, Valter ^b   Quinn, David I ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Chemotherapy; Fasting; Insulin like growth factor; Neutropenia; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC METAL COMPLEX; ASPARTATE AMINOTRANSFERASE; CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; GLUCOSE; INSULIN; KETONE; PACLITAXEL; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TRASTUZUMAB; BIOLOGICAL MARKER; IGF1 PROTEIN, HUMAN; PLATINUM;

ADULT; ADVERSE OUTCOME; AGED; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COMET ASSAY; CONSTIPATION; DIARRHEA; DIET RESTRICTION; DISEASE SEVERITY; DIZZINESS; DNA DAMAGE; DRUG SAFETY; FATIGUE; FEASIBILITY STUDY; FEMALE; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; HYPONATREMIA; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; NON SMALL CELL LUNG CANCER; OVARY CANCER; OXIDATIVE STRESS; PERIPHERAL NEUROPATHY; SIDE EFFECT; THROMBOCYTOPENIA; UROGENITAL TRACT CANCER; UTERUS CANCER; VOMITING; BLOOD; METABOLISM; MIDDLE AGED; NEOPLASMS; TREATMENT OUTCOME;

ADULT; AGED; BIOMARKERS; FASTING; FEASIBILITY STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEOPLASMS; OXIDATIVE STRESS; PLATINUM; TREATMENT OUTCOME;

EID: 84973547651     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-016-2370-6     Document Type: Article

References (27)

1. Appenroth D, Frob S, Kersten L, et al. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol. 1997;71:677-83.
2. DeMartinis BS, Bianchi MD. Effect of vitamin C supplementation against cisplatin-induced toxicity and oxidative DNA damage in rats. Pharmacol Res. 2001;44:317-20.
3. Yuce A, Atessahin A, Ceribasi AO, Aksakal M. Ellagic acid prevents cisplatin induced oxidative stress in liver and heart tissue of rats. Basic Clin Pharm Toxicol. 2007;101:345-9.
4. Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer. 2008;123:1227-39.
5. Raffaghello L, Lee C, Safdie FM, et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci. 2008;105:8215-20.
6. Csizsar A, Labinskyy N, Jimenez R, et al. Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT-1. Mech Age Develop. 2009;130:518-27.
7. Lee C, Raffaghello L, Brandhorst S, et al. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med. 2012;4:124-7.
8. Mansell PI, Macdonald IA. The effect of starvation on insulin-induced glucose disposal and thermogenesis in humans. Metabolism. 1990;39:502-10.
9. Romijin JA, Godfried MH, Hommes MJT, et al. Decreased glucose oxidation during short-term starvation. Metabolism. 1990;39:525-30.
10. NgoTH BRJ, Tymchuk CN, et al. Effect of diet and exercise on serum insulin, IGF-1, and IGFBP-1 levels and growth of LNCaP Cells in Vitro. Cancer Causes Control. 2002;13:929-35.
11. O'Sullivan U, Gluckman PD, Breier BH, et al. Insulin-like growth factor-1 (IGF-1) in mice reduces weight loss during starvation. Endocrinology. 1989;125:2793-4.
12. Muzumdar RH, Ma X, Fishman S, Yang X, Atzmon G, et al. Central and opposing effects of IGF-1 and IGF-binding protein-3 on systemic insulin action. Diabetes. 2006;55:2788-96.
13. Milman S, Atzmon G, Huffman DM, Wan J, Crandall JP, et al. Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity. Aging Cell. 2014;13:769-71.
14. Ostling O, Johanson KJ. Biochem Biophys Res Commun. 1984;123:291-8.
15. Olive PL, Wlodek D, Durand RE, Banath JP. Factors influencing DNA migration from individual cells subjected to gel electrophoresis. Exp Cell Res. 1992;198:259-67.
16. Everitt AV, LeCouteur DG. Life extension by calorie restriction in humans. Ann NY Acad Sci. 2007;1114:428-33.
17. Dunn SE, Ehrlich M, Sharp NJH, et al. A dominant negative mutant of the insulin-like growth factor-1 receptor inhibits the adhesion, invasion and metastasis of breast cancer. Cancer Res. 1998;58:3353-61.
18. Kritchevsky D. Diet and cancer: what's next? J Nutr. 2003;133:3827S-9.
19. Lee C, Safdie FM, Raffaghello L, et al. Reduced levels of IGF-1 mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Res. 2010;70:1564-72.
20. Rock CL, Demark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol. 2002;20:3302-16.
21. Chan JM, Gann PH, Giovannucci GL. Role of diet in prostate cancer development and progression. J Clin Oncol. 2005;23:8152-60.
22. Kjeldsen-Kragh J, Borchgrevink CF, Laerum E, et al. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet. 1991;338:899-902.
23. Varady KA, Hellerstein MK. Alternate day fasting and chronic disease prevention: a review of human and animal trials. Am J Clin Nutr. 2007;86:7-13.
24. Weindruch R, Sohal RS. Caloric intake and aging. New Engl J Med. 1997;337:986-94.
25. Ngo TH, Barnard RJ, Anton T, Tran C, Elashoff D, Heber D, et al. Effect of isocaloric low-fat diet on prostate cancer xenograft progression to androgen independence. Cancer Res. 2004;64:1252.
26. Smith WJ, Underwood LE, Clemmons DR. Effects of caloric or protein restriction on insulin-like growth factor-1 (IGF-1) and IGF-binding protein in children and adults. J Clin Endocrinol Metab. 1995;80:443-9.
27. Cheng C-W, Adams GB, Perin L, et al. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic stem cell-based regeneration and reverse immunosuppression. Cell Stem Cell. 2014;14:810-23.